Subject Index to Volume 73 JANUARY-DE(MEMBER 1976
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Ferric Reductase Activity of the Arsh Protein from Acidithiobacillus Ferrooxidans
J. Microbiol. Biotechnol. (2011), 21(5), 464–469 doi: 10.4014/jmb.1101.01020 First published online 13 April 2011 Ferric Reductase Activity of the ArsH Protein from Acidithiobacillus ferrooxidans Mo, Hongyu1,2, Qian Chen1,2, Juan Du1, Lin Tang1, Fang Qin1, Bo Miao2, Xueling Wu2, and Jia Zeng1,2* 1College of Biology, Hunan University, Changsha, Hunan 410082, P. R. China 2Department of Bioengineering, Central South University, Changsha, Hunan 410083, P. R. China Received: January 14, 2011 / Revised: March 10, 2011 / Accepted: March 11, 2011 The arsH gene is one of the arsenic resistance system in iron (free or chelated) into ferrous iron before its incorporation bacteria and eukaryotes. The ArsH protein was annotated into heme and nonheme iron-containing proteins. Ferric as a NADPH-dependent flavin mononucleotide (FMN) reductase catalyzes the reduction of complexed Fe3+ to reductase with unknown biological function. Here we complexed Fe2+ using NAD(P)H as the electron donor. The report for the first time that the ArsH protein showed resulting Fe2+ is subsequently released and incorporated high ferric reductase activity. Glu104 was an essential into iron-containing proteins [17]. residue for maintaining the stability of the FMN cofactor. Here we report for the first time that the ArsH protein The ArsH protein may perform an important role for showed high ferric reduction activity. The ArsH from A. cytosolic ferric iron assimilation in vivo. ferrooxidans may perform an important role as a NADPH- Keywords: Acidithiobacillus ferrooxidans, ArsH, flavoprotein, dependent ferric reductase for cytosolic ferric iron assimilation ferric reductase in vivo. MATERIALS AND METHODS Arsenic resistance genes are widespread in nature. -
Anticonvulsants
ALZET® Bibliography References on the Administration of Anticonvulsive Agents Using ALZET Osmotic Pumps 1. Carbamazepine Q5784: K. Deseure, et al. Differential drug effects on spontaneous and evoked pain behavior in a model of trigeminal neuropathic pain. J Pain Res 2017;10(279-286 ALZET Comments: Carbamazepine, baclofen, clomipramine; DMSO, PEG, Ethyl Alcohol, Acetone; SC; Rat; 2ML1; Controls received mp w/ vehicle; animal info (7 weeks old); dimethyl sulfoxide, propylene glycol, ethyl alcohol, and acetone at a ratio of 42:42:15:1; post op. care (morphine 5 mg/day); behavioral testing (Facial grooming); Therapeutic indication (Trigeminal neuralgia, neuropathic pain); Dose (30 mg/day carbamazepine (the first-line drug treatment for trigeminal neuralgia), 1.06 mg/day baclofen, 4.18 mg/day clomipramine, and 5 mg/day morphine);. Q0269: S. M. Cain, et al. High resolution micro-SPECT scanning in rats using 125I beta-CIT: Effects of chronic treatment with carbamazepine. Epilepsia 2009;50(8):1962-1970 ALZET Comments: Carbamazepine; DMSO; propylene glycol; ethyl alcohol; acetone; SC; Rat; 2ML2; 14 days; Controls received mp w/ vehicle; animal info (adult, male, Sprague-Dawley, 160-270 g); functionality of mp verified by serum drug levels; 42% DMSO used; identified 3 mg/kg/day as the highest dose that could be reliably administered via minipumps over a 14-day period at 37 degrees Celsius, pg. 1969. P5195: H. C. Doheny, et al. A comparison of the efficacy of carbamazepine and the novel anti-epileptic drug levetiracetam in the tetanus toxin model of focal complex partial epilepsy. British Journal of Pharmacology 2002;135(6):1425-1434 ALZET Comments: Carbamazepine; levetiracetam; DMSO; Propylene glycol; ethanol, saline; IP; Rat; 7 days; Controls received mp/ vehicle; functionality of mp verified by drug serum levels; dose-response (text p.1428); carbamazepine was dissolved in 42.5% DMSO/42% Propylene glycol/15% ethanol. -
Proteínas De Superfície De Paracoccidioides Brasiliensis
UNIVERSIDADE DE BRASÍLIA FACULDADE DE MEDICINA PROGRAMA DE PÓS-GRADUAÇÃO EM PATOLOGIA MOLECULAR Proteínas de superfície de Paracoccidioides brasiliensis CANDIDATA: NADYA DA SILVA CASTRO ORIENTADORA: DRA. CÉLIA MARIA DE ALMEIDA SOARES TESE APRESENTADA AO PROGRAMA DE PÓS-GRADUAÇÃO EM PATOLOGIA MOLECULAR, DA FACULDADE DE MEDICINA, DA UNIVERSIDADE DE BRASÍLIA COMO REQUISITO PARCIAL À OBTENÇÃO DO TÍTULO DE DOUTOR EM PATOLOGIA MOLECULAR. BRASÍLIA – DF MAIO 2008 TRABALHO REALIZADO NO LABORATÓRIO DE BIOLOGIA MOLECULAR, DEPARTAMENTO DE BIOQUÍMICA E BIOLOGIA MOLECULAR, INSTITUTO DE CIÊNCIAS BIOLÓGICAS, DA UNIVERSIDADE FEDERAL DE GOIÁS. APOIO FINANCEIRO: CAPES/ CNPQ/ FINEP/ FAPEG/ SECTEC-GO. II BANCA EXAMINADORA TITULARES Profa. Dra. Célia Maria de Almeida Soares, Instituto de Ciências Biológicas, Universidade Federal de Goiás. Prof. Dr. Augusto Schrank Centro de Biotecnologia, Universidade Federal do Rio Grande do Sul Prof. Dr. Ivan Torres Nicolau de Campos Instituto de Ciências Biológicas, Universidade Federal de Goiás. Prof. Dr. Bergmann Morais Ribeiro Instituto de Ciências Biológicas, Universidade de Brasília. Prof. Dra. Anamélia Lorenzetti Bocca Instituto de Ciências Biológicas, Universidade de Brasília. SUPLENTE Prof. Dr. Fernando Araripe Gonçalves Torres Instituto de Ciências Biológicas, Universidade de Brasília. III ´- Os homens do seu planeta ² disse o pequeno Príncipe ² cultivam cinco mil rosas num jardim... e não encontram o que procuram... - É verdade ² respondi. - E, no entanto, o que eles procuram poderia ser encontrado numa só rosa, ou num pouco de água... - É verdade. E o principezinho acrescentou: Mas os olhos são cegos. eSUHFLVRYHUFRPRFRUDomRµ ³O pequeno príncipe´ de Antonie de Saint-Exupéry IV Dedico esta tese aos meus queridos pais, Nadson e Genialda, que foram e são exemplos de dedicação e de perseverança e cujos incentivos, apoio e amor contribuíram em muito para a realização deste trabalho. -
Updating the Sequence-Based Classification of Glycosyl Hydrolases
Article Updating the sequence-based classification of glycosyl hydrolases HENRISSAT, Bernard, BAIROCH, Amos Marc Reference HENRISSAT, Bernard, BAIROCH, Amos Marc. Updating the sequence-based classification of glycosyl hydrolases. Biochemical Journal, 1996, vol. 316 ( Pt 2), p. 695-6 PMID : 8687420 DOI : 10.1042/bj3160695 Available at: http://archive-ouverte.unige.ch/unige:36909 Disclaimer: layout of this document may differ from the published version. 1 / 1 Biochem. J. (1996) 316, 695–696 (Printed in Great Britain) 695 BIOCHEMICAL JOURNAL Updating the sequence-based classification of available. When the number of glycosyl hydrolase sequences reached C 480, ten additional families (designated 36–45) could glycosyl hydrolases be defined and were added to the classification [2]. There are at present over 950 sequences of glycosyl hydrolases in the data- A classification of glycosyl hydrolases based on amino-acid- banks (EMBL}GenBank and SWISS-PROT). Their analysis sequence similarities was proposed in this Journal a few years shows that the vast majority of the C 470 additional sequences ago [1]. This classification originated from the analysis of C 300 that have become available since the last update could be classified sequences and their grouping into 35 families designated 1–35. in the existing families. However, several sequences not fitting Because such a classification is necessarily sensitive to the sample, the existing families allow the definition of new families (desig- it was anticipated that it was incomplete and that new families nated 46–57) (Table 1). When the several present genome would be determined when additional sequences would become sequencing projects have reached completion, the number of Table 1 New families in the classification of glycosyl hydrolases Family Enzyme Organism SWISS-PROT EMBL/GenBank 46 Chitosanase Bacillus circulans MH-K1 P33673 D10624 46 Chitosanase Streptomyces sp. -
Yeast Genome Gazetteer P35-65
gazetteer Metabolism 35 tRNA modification mitochondrial transport amino-acid metabolism other tRNA-transcription activities vesicular transport (Golgi network, etc.) nitrogen and sulphur metabolism mRNA synthesis peroxisomal transport nucleotide metabolism mRNA processing (splicing) vacuolar transport phosphate metabolism mRNA processing (5’-end, 3’-end processing extracellular transport carbohydrate metabolism and mRNA degradation) cellular import lipid, fatty-acid and sterol metabolism other mRNA-transcription activities other intracellular-transport activities biosynthesis of vitamins, cofactors and RNA transport prosthetic groups other transcription activities Cellular organization and biogenesis 54 ionic homeostasis organization and biogenesis of cell wall and Protein synthesis 48 plasma membrane Energy 40 ribosomal proteins organization and biogenesis of glycolysis translation (initiation,elongation and cytoskeleton gluconeogenesis termination) organization and biogenesis of endoplasmic pentose-phosphate pathway translational control reticulum and Golgi tricarboxylic-acid pathway tRNA synthetases organization and biogenesis of chromosome respiration other protein-synthesis activities structure fermentation mitochondrial organization and biogenesis metabolism of energy reserves (glycogen Protein destination 49 peroxisomal organization and biogenesis and trehalose) protein folding and stabilization endosomal organization and biogenesis other energy-generation activities protein targeting, sorting and translocation vacuolar and lysosomal -
United States Patent (19) (11) 4,310,524 Wiech Et Al
United States Patent (19) (11) 4,310,524 Wiech et al. 45 Jan. 12, 1982 (54) TCA COMPOSITION AND METHOD FOR McMillen et al., Fed. Proc., 38,592 (1979). RAPD ONSET ANTDEPRESSANT Sellinger et al., Fed. Proc., 38,592 (1979). THERAPY Pandey et al., Fed. Proc., 38,592 (1979). 75) Inventors: Norbert L. Wiech; Richard C. Ursillo, Primary Examiner-Stanley J. Friedman both of Cincinnati, Ohio Attorney, Agent, or Firm-Millen & White 73) Assignee: Richardson-Merrell, Inc., Wilton, Conn. (57 ABSTRACT A method is provided for treating depression in a pa (21) Appl. No.: 139,498 tient therefrom and requiring rapid symptomatic relief, (22 Filed: Apr. 11, 1980 which comprises administering to said patient concur 51) Int. Cl. .................... A61K 31/33; A61K 31/135 rently (a) an effective antidepressant amount of a tricy clic antidepressant or a pharmaceutically effective acid (52) ...... 424/244; 424/330 addition salt thereof, and (b) an amount of an a-adrener 58) Field of Search ................................ 424/244, 330 gic receptor blocking agent effective to achieve rapid (56) References Cited onset of the antidepressant action of (a), whereby the PUBLICATIONS onset of said antidepressant action is achieved within Chemical Abst., vol. 66-72828m, (1967), Kellett. from 1 to 7 days. Chemical Abst, vol. 68-94371a, (1968), Martelli et al. A pharmaceutical composition is also provided which is Chemical Abst., vol. 74-86.048j, (1971), Dixit et al. especially adapted for use with the foregoing method. Holmberg et al., Psychopharm., 2,93 (1961). Svensson, Symp. Med. Hoechst., 13, 245 (1978). 17 Claims, No Drawings 4,310,524 1. -
Supplementary Table 16 Components of the Secretory Pathway
Supplementary Table 16 Components of the secretory pathway Aspergillus niger Description of putative Aspergillus niger gene Best homolog to putative A.niger gene A.niger orf A.niger A.nidulans A.fumigatus A.oryzae N.crassa S.cerevisiae Mammal gene Entry into ER Signal recognition YKL122c An01g02800 strong similarity to signal recognition particle 68K protein SRP68 - AN4043.2 Afu1g03940 AO090003000956 NCU10927.2 YPL243w Canis lupus An04g06890 similarity to 72-kD protein of the signal recognition particle SRP72 -AN2014.2 Afu4g10180 AO090003001205 NCU01455.2 YPL210c Canis lupus An01g10070 strong similarity to signal recognition particle chain Sec65 - AN0643.2 Afu1g16820 NCU03485.2 YML105c Saccharomyces cerevisiae AN0642.2 An15g06470 similarity to signal sequence receptor alpha chain - Canis lupus AN2140.2 Afu2g16120 AO090012000186 NCU01146.2 familiaris An07g05800 similarity to signal recognition particle protein srp14 - Canis lupus AN4580.2 Afu2g01990 AO090011000469 YDL092w An09g06320 similarity to signal recognition particle 54K protein SRP54 - AN8246.2 Afu5g03880 AO090102000593 NCU09696.2 YPR088c Saccharomyces cerevisiae Signal peptidase An01g00560 strong similarity to signal peptidase subunit Sec11 - AN3126.2 Afu3g12840 AO090012000838 NCU04519.2 YIR022w Saccharomyces cerevisiae An17g02095 similarity to signal peptidase subunit Spc1 - Saccharomyces Afu5g05800 YJR010c-a cerevisiae An16g07390 strong similarity to signal peptidase subunit Spc2 - AN1525.2 Afu8g05340 AO090005000615 NCU00965.2 YML055w Saccharomyces cerevisiae An09g05420 similarity -
Generate Metabolic Map Poster
Authors: Pallavi Subhraveti Anamika Kothari Quang Ong Ron Caspi An online version of this diagram is available at BioCyc.org. Biosynthetic pathways are positioned in the left of the cytoplasm, degradative pathways on the right, and reactions not assigned to any pathway are in the far right of the cytoplasm. Transporters and membrane proteins are shown on the membrane. Ingrid Keseler Peter D Karp Periplasmic (where appropriate) and extracellular reactions and proteins may also be shown. Pathways are colored according to their cellular function. Csac1394711Cyc: Candidatus Saccharibacteria bacterium RAAC3_TM7_1 Cellular Overview Connections between pathways are omitted for legibility. Tim Holland TM7C00001G0420 TM7C00001G0109 TM7C00001G0953 TM7C00001G0666 TM7C00001G0203 TM7C00001G0886 TM7C00001G0113 TM7C00001G0247 TM7C00001G0735 TM7C00001G0001 TM7C00001G0509 TM7C00001G0264 TM7C00001G0176 TM7C00001G0342 TM7C00001G0055 TM7C00001G0120 TM7C00001G0642 TM7C00001G0837 TM7C00001G0101 TM7C00001G0559 TM7C00001G0810 TM7C00001G0656 TM7C00001G0180 TM7C00001G0742 TM7C00001G0128 TM7C00001G0831 TM7C00001G0517 TM7C00001G0238 TM7C00001G0079 TM7C00001G0111 TM7C00001G0961 TM7C00001G0743 TM7C00001G0893 TM7C00001G0630 TM7C00001G0360 TM7C00001G0616 TM7C00001G0162 TM7C00001G0006 TM7C00001G0365 TM7C00001G0596 TM7C00001G0141 TM7C00001G0689 TM7C00001G0273 TM7C00001G0126 TM7C00001G0717 TM7C00001G0110 TM7C00001G0278 TM7C00001G0734 TM7C00001G0444 TM7C00001G0019 TM7C00001G0381 TM7C00001G0874 TM7C00001G0318 TM7C00001G0451 TM7C00001G0306 TM7C00001G0928 TM7C00001G0622 TM7C00001G0150 TM7C00001G0439 TM7C00001G0233 TM7C00001G0462 TM7C00001G0421 TM7C00001G0220 TM7C00001G0276 TM7C00001G0054 TM7C00001G0419 TM7C00001G0252 TM7C00001G0592 TM7C00001G0628 TM7C00001G0200 TM7C00001G0709 TM7C00001G0025 TM7C00001G0846 TM7C00001G0163 TM7C00001G0142 TM7C00001G0895 TM7C00001G0930 Detoxification Carbohydrate Biosynthesis DNA combined with a 2'- di-trans,octa-cis a 2'- Amino Acid Degradation an L-methionyl- TM7C00001G0190 superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis (E. -
The Human Flavoproteome
CORE Metadata, citation and similar papers at core.ac.uk Provided by Elsevier - Publisher Connector Archives of Biochemistry and Biophysics 535 (2013) 150–162 Contents lists available at SciVerse ScienceDirect Archives of Biochemistry and Biophysics journal homepage: www.elsevier.com/locate/yabbi Review The human flavoproteome ⇑ Wolf-Dieter Lienhart, Venugopal Gudipati, Peter Macheroux Graz University of Technology, Institute of Biochemistry, Petersgasse 12, A-8010 Graz, Austria article info abstract Article history: Vitamin B2 (riboflavin) is an essential dietary compound used for the enzymatic biosynthesis of FMN and Received 17 December 2012 FAD. The human genome contains 90 genes encoding for flavin-dependent proteins, six for riboflavin and in revised form 21 February 2013 uptake and transformation into the active coenzymes FMN and FAD as well as two for the reduction to Available online 15 March 2013 the dihydroflavin form. Flavoproteins utilize either FMN (16%) or FAD (84%) while five human flavoen- zymes have a requirement for both FMN and FAD. The majority of flavin-dependent enzymes catalyze Keywords: oxidation–reduction processes in primary metabolic pathways such as the citric acid cycle, b-oxidation Coenzyme A and degradation of amino acids. Ten flavoproteins occur as isozymes and assume special functions in Coenzyme Q the human organism. Two thirds of flavin-dependent proteins are associated with disorders caused by Folate Heme allelic variants affecting protein function. Flavin-dependent proteins also play an important role in the Pyridoxal 50-phosphate biosynthesis of other essential cofactors and hormones such as coenzyme A, coenzyme Q, heme, pyri- Steroids doxal 50-phosphate, steroids and thyroxine. Moreover, they are important for the regulation of folate Thyroxine metabolites by using tetrahydrofolate as cosubstrate in choline degradation, reduction of N-5.10-meth- Vitamins ylenetetrahydrofolate to N-5-methyltetrahydrofolate and maintenance of the catalytically competent form of methionine synthase. -
THE ALPHA-GALACTOSIDASE SUPERFAMILY: SEQUENCE BASED CLASSIFICATION of ALPHA-GALACTOSIDASES and RELATED GLYCOSIDASES Naumoff D.G
COMPUTATIONAL STRUCTURAL AND FUNCTIONAL PROTEOMICS THE ALPHA-GALACTOSIDASE SUPERFAMILY: SEQUENCE BASED CLASSIFICATION OF ALPHA-GALACTOSIDASES AND RELATED GLYCOSIDASES Naumoff D.G. State Institute for Genetics and Selection of Industrial Microorganisms, Moscow, Russia, e-mail: [email protected] Keywords: α-galactosidase, melibiase, glycoside hydrolase, GH-D clan, GH31 family, GHX family, COG1649, enzyme classification, protein family, protein phylogeny Summary Motivation: About 1 % of genes in genomes code enzymes with glycosidase activities. On the basis of sequence similarity all known glycosidases have been classified into 90 families. In many cases proteins of different families have common evolution origin. It makes necessary to combine the corresponding families into a superfamily. Results: Using of the PSI-BLAST program we found significant sequence similarity of several glycosidase families, two of which includes enzymes with the α galactosidase activity. Sequence homology, common catalytic mechanism, folding similarities, and composition of the active center allowed us to group three of these families – GH27, GH31, and GH36 – into the α-galactosidase superfamily. Phylogenetic analysis of this superfamily revealed polyphyletic origin of GH36 family, which could be divided into four families. Glycosidases of the α-galactosidase superfamily have a distant relationship with proteins belonging to families GH13, GH70, and GH77 of glycosidases, as well as with two families of predicted glycosidases. Introduction Glycoside hydrolases or glycosidases (EC 3.2.1.-) are a widespread group of enzymes, hydrolyzing the glycosidic bonds between two carbohydrates or between a carbohydrate and an aglycone moiety. A large multiplicity of these enzymes is a consequence of the extensive variety of their natural substrates: di-, oligo-, and polysaccharides. -
Molecular Cloning, Expression, and Functional Analysis of the Chitin
www.nature.com/scientificreports OPEN Molecular cloning, expression, and functional analysis of the chitin synthase 1 gene and its two Received: 22 March 2018 Accepted: 7 December 2018 alternative splicing variants in Published: xx xx xxxx the white-backed planthopper, Sogatella furcifera (Hemiptera: Delphacidae) Zhao Wang1,2, Hong Yang1,3, Cao Zhou1, Wen-Jia Yang4, Dao-Chao Jin1 & Gui-Yun Long1 Chitin synthase is responsible for chitin synthesis in the cuticles and cuticular linings of other tissues in insects. We cloned two alternative splicing variants of the chitin synthase 1 gene (SfCHS1) from the white-backed planthopper, Sogatella furcifera. The full-length cDNA of the two variants (SfCHS1a and SfCHS1b) consists of 6408 bp, contains a 4719-bp open reading frame encoding 1572 amino acids, and has 5′ and 3′ non-coding regions of 283 and 1406 bp, respectively. The two splicing variants occur at the same position in the cDNA sequence between base pairs 4115 and 4291, and consist of 177 nucleotides that encode 59 amino acids but show 74.6% identity at the amino acid level. Analysis in diferent developmental stages showed that expression of SfCHS1 and SfCHS1a were highest just after molting, whereas SfCHS1b reached its highest expression level 2 days after molting. Further, SfCHS1 and SfCHS1a were mainly expressed in the integument, whereas SfCHS1b was predominately expressed in the gut and fat body. RNAi-based gene silencing inhibited transcript levels of the corresponding mRNAs in S. furcifera nymphs injected with double-stranded RNA of SfCHS1, SfCHS1a, and SfCHS1b, resulted in malformed phenotypes, and killed most of the treated nymphs. -
Reaction Mechanism of Azoreductases Suggests Convergent Evolution with Quinone Oxidoreductases
Protein Cell 2010, 1(8): 780–790 Protein & Cell DOI 10.1007/s13238-010-0090-2 RESEARCH ARTICLE Reaction mechanism of azoreductases suggests convergent evolution with quinone oxidoreductases ✉ Ali Ryan*, Chan-Ju Wang*, Nicola Laurieri*, Isaac Westwood, Edith Sim Department of Pharmacology, University of Oxford, Mansfield Road, Oxford, OX1 3QT, UK ✉ Correspondence: [email protected] Received June 2, 2010 Accepted June 28, 2010 ABSTRACT the dye used for dying fabrics does not bind to the fabric, and as a result, is lost in the effluent (Shore, 1995). As these dyes Azoreductases are involved in the bioremediation by can be carcinogenic (Alves de Lima et al., 2007) their removal bacteria of azo dyes found in waste water. In the gut flora, from the effluent is essential. This has driven investigations they activate azo pro-drugs, which are used for treatment into both electrochemical reduction of azo dyes (Wang et al., of inflammatory bowel disease, releasing the active 2010b), as well as the use of both aerobic and anaerobic component 5-aminosalycilic acid. The bacterium bacteria for bioremediation (dos Santos et al., 2007; You et P. aeruginosa has three azoreductase genes, paAzoR1, al., 2007). paAzoR2 and paAzoR3, which as recombinant enzymes Azo bonds are also found in some drugs including those have been shown to have different substrate specifici- used for the treatment of inflammatory bowel disease (IBD). ties. The mechanism of azoreduction relies upon tauto- Azo compounds have also been shown to be effective merisation of the substrate to the hydrazone form. We antibacterial (Farghaly and Abdalla, 2009) and antitumor (El- report here the characterization of the P.